Brodalumab Subcutaneous and Oxcarbazepine Extended-Release Tablets
Determining the interaction of Brodalumab Subcutaneous and Oxcarbazepine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brodalumab
Brand name: Siliq
Synonyms: Brodalumab
Generic Name: oxcarbazepine
Brand name: Oxtellar XR, Trileptal
Synonyms: Oxcarbazepine, OXcarbazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brodalumab Subcutaneous-Oxcarbazepine Oral Suspension
- Brodalumab Subcutaneous-Oxcarbazepine Suspension
- Brodalumab Subcutaneous-Oxcarbazepine Tablets
- Brodalumab Subcutaneous-Oxecta
- Brodalumab Subcutaneous-Oxilan
- Brodalumab Subcutaneous-Oxipor VHC
- Oxcarbazepine Extended-Release Tablets-Brodspec
- Oxcarbazepine Extended-Release Tablets-Brom Mal Phenyl HCl Dex HBr
- Oxcarbazepine Extended-Release Tablets-Bromaline
- Oxcarbazepine Extended-Release Tablets-Bromaline DM
- Oxcarbazepine Extended-Release Tablets-Bromatan Plus
- Oxcarbazepine Extended-Release Tablets-Bromatan-DM